Maternal caffeine consumption during pregnancy and the risk of miscarriage: a prospective cohort study - 21/08/11
Reprints: Dr. De-Kun Li, Division of Research, Kaiser Foundation Research Institute, Kaiser Permanente, 2000 Broadway, Oakland, CA 94612.Résumé |
Objective |
The objective of the study was to examine whether the risk of miscarriage is associated with caffeine consumption during pregnancy after controlling for pregnancy-related symptoms.
Study Design |
This was a population-based prospective cohort study.
Results |
An increasing dose of daily caffeine intake during pregnancy was associated with an increased risk of miscarriage, compared with no caffeine intake, with an adjusted hazard ratio (aHR) of 1.42 (95% confidence interval 0.93 to 2.15) for caffeine intake of less than 200 mg/day, and aHR of 2.23 (1.34 to 3.69) for intake of 200 or more mg/day, respectively. Nausea or vomiting during pregnancy did not materially affect this observed association, nor did the change in intake pattern of caffeine during pregnancy. In addition, the magnitude of the association appeared to be stronger among women without a history of miscarriage (aHR 2.33, 1.48 to 3.67) than that among women with such a history (aHR 0.81, 0.34 to 1.94).
Conclusion |
Our results demonstrated that high doses of caffeine intake during pregnancy increase the risk of miscarriage, independent of pregnancy-related symptoms.
Le texte complet de cet article est disponible en PDF.Key words : abortion, caffeine, miscarriage, spontaneous
Plan
| This study was supported in part by the California Public Health Foundation. |
|
| Cite this article as: Weng X, Odouli R, and Li D-K. Maternal caffeine consumption during pregnancy and the risk of miscarriage: a prospective cohort study. Am J Obstet Gynecol 2008;198:279.e1-279.e8. |
Vol 198 - N° 3
P. 279.e1-279.e8 - mars 2008 Retour au numéro
Article précédent
- Detection of perimenopause or postmenopause human chorionic gonadotropin: an unnecessary source of alarm
- Laurence A. Cole, Sarah A. Khanlian, Carolyn Y. Muller
- Maternal C-reactive protein and developmental programming of atherosclerosis
- Antonio Liguori, Francesco P. D’Armiento, Antonio Palagiano, Wulf Palinski, Claudio Napoli
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?